immunomodulators (Yale University/Boehringer Ingelheim)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameimmunomodulators (Yale University/Boehringer Ingelheim)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesRespiratory Tract DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesRespiratory Tract DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A